Latest Conference Articles

Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.

An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.

Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.

Let us know if you plan to attend IMCAS World Congress 2024.

A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.

A poster from Maui Derm Hawaii revealed an even more significant disparity than researchers anticipated.

Patients with moderate to severe AD gave their opinions in a survey on treatment options and their tradeoffs. Itch control topped the list of patient concerns.

Researchers from Pyeongchon, Korea, argue that evidence points to the need for a change in the terminology of "freckling," according to a poster from Maui Derm Hawaii.

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.

The VISIBLE clinical program will create a longitudinal collection of more than 20,000 clinical images across all skin tones.

Among the many sessions to be held at the Maui Derm Hawaii 2024 conference on Maui, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll.

The Winter Clinical Hawaii session delved into a spectrum of skin conditions, treatments, and common practice challenges.

Emmy Graber, MD, MBA, shared the truth behind cosmeceutical trends that patients may ask about from snail mucin to skin care refrigerators.

Seemal Desai, MD, highlighted the challenges and opportunities to best serve patients seeking solutions for acne scars, melasma, vitiligo, and cosmetic concerns.

The pooled analyses from Arcutis’ INTEGUMENT-1 and INTEGUMENT-2 studies were presented at the 2024 Winter Clinical Hawaii Dermatology Conference.

Data from Arcutis’ STRATUM study was presented at the 2024 Winter Clinical Hawaii Dermatology Conference.

The promising results were presented in a poster at the 2024 Winter Clinical Hawaii Dermatology Conference in Honolulu, Hawaii.

Ten posters at the Winter Clinical Hawaii and Maui Derm Conferences will showcase investigational data to expand treatment options for patients with atopic dermatitis and chronic hand eczema.

Among the many sessions to be held at the 2024 Winter Clinical Dermatology Conference in Honolulu, Hawaii, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll.

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

A late breaking session from Revolutionizing Atopic Dermatitis Virtual Conference analyzed the frequency and clinical meaningfulness of conjunctivitis.

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

Catch up on Dermatology Times conference coverage from July through December of this year.

Catch up on Dermatology Times conference coverage from January through June of this year.

The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.